Monashee Investment Management LLC Mersana Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

  • $774 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$2.16 - $5.94 $669,600 - $1.84 Million
310,000 New
310,000 $1.39 Million
Q3 2020

Nov 13, 2020
SELL
$16.2 - $25.7 $4.86 Million - $7.71 Million
-300,000 Closed
0 $0
Q2 2020

Aug 11, 2020
BUY
$5.24 - $23.4 $1.57 Million - $7.02 Million
300,000 New
300,000 $7.02 Million

Others Institutions Holding MRSN

# of Institutions
121
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $216M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email